Thomas Flaten
Stock Analyst at Lake Street
(4.36)
# 1,290
Out of 5,044 analysts
336
Total ratings
48.1%
Success rate
8.5%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATHE Alterity Therapeutics | Reiterated: Buy | $10 | $3.12 | +221.03% | 3 | Oct 5, 2026 | |
| HROW Harrow | Reiterated: Buy | $60 | $29.36 | +104.36% | 21 | Oct 5, 2026 | |
| AEON AEON Biopharma | Reiterated: Buy | $1 → $2 | $0.276 | +624.64% | 3 | Oct 1, 2026 | |
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $9 | $0.87 | +934.48% | 5 | Oct 1, 2026 | |
| CSTL Castle Biosciences | Reiterated: Buy | $57 | $34.42 | +65.60% | 26 | Oct 1, 2026 | |
| VRCA Verrica Pharmaceuticals | Reiterated: Buy | $9 | $4.11 | +118.98% | 2 | Oct 1, 2026 | |
| BDSX Biodesix | Reiterated: Buy | $40 | $26.02 | +53.73% | 15 | Sep 24, 2026 | |
| AYTU Aytu BioPharma | Reiterated: Buy | $7 | $2.03 | +245.68% | 7 | Sep 23, 2026 | |
| QNRX Quoin Pharmaceuticals | Initiated Coverage: Buy | $20 | $4.50 | +344.44% | 1 | Sep 23, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $6 | $4.78 | +25.52% | 38 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.07 | +193.16% | 26 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $16.00 | +1.56% | 32 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.37 | +256.08% | 26 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.8935 | +683.44% | 9 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $8.33 | +68.07% | 23 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $6.31 | +106.02% | 15 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $5 | $0.5897 | +747.89% | 14 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $12.40 | +93.55% | 1 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $7.41 | +48.45% | 30 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $20.50 | +143.90% | 5 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.60 | n/a | 15 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 | $0.0001 | n/a | 8 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 → $15 | $0.527 | n/a | 3 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 | $0.7858 | n/a | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $50 | $45.23 | n/a | 4 | Mar 1, 2022 |
Alterity Therapeutics
Oct 5, 2026
Reiterated: Buy
Price Target: $10
Current: $3.12
Upside: +221.03%
Harrow
Oct 5, 2026
Reiterated: Buy
Price Target: $60
Current: $29.36
Upside: +104.36%
AEON Biopharma
Oct 1, 2026
Reiterated: Buy
Price Target: $1 → $2
Current: $0.276
Upside: +624.64%
Connect Biopharma Holdings
Oct 1, 2026
Reiterated: Buy
Price Target: $9
Current: $0.87
Upside: +934.48%
Castle Biosciences
Oct 1, 2026
Reiterated: Buy
Price Target: $57
Current: $34.42
Upside: +65.60%
Verrica Pharmaceuticals
Oct 1, 2026
Reiterated: Buy
Price Target: $9
Current: $4.11
Upside: +118.98%
Biodesix
Sep 24, 2026
Reiterated: Buy
Price Target: $40
Current: $26.02
Upside: +53.73%
Aytu BioPharma
Sep 23, 2026
Reiterated: Buy
Price Target: $7
Current: $2.03
Upside: +245.68%
Quoin Pharmaceuticals
Sep 23, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $4.50
Upside: +344.44%
Aquestive Therapeutics
Sep 17, 2026
Reiterated: Buy
Price Target: $6
Current: $4.78
Upside: +25.52%
Aug 21, 2026
Reiterated: Buy
Price Target: $9
Current: $3.07
Upside: +193.16%
Aug 21, 2026
Reiterated: Hold
Price Target: $16
Current: $16.00
Upside: +1.56%
Aug 18, 2026
Reiterated: Buy
Price Target: $12
Current: $3.37
Upside: +256.08%
Aug 10, 2026
Reiterated: Buy
Price Target: $7
Current: $0.8935
Upside: +683.44%
Jun 23, 2026
Reiterated: Buy
Price Target: $14
Current: $8.33
Upside: +68.07%
May 14, 2026
Reiterated: Buy
Price Target: $13
Current: $6.31
Upside: +106.02%
May 14, 2026
Reiterated: Buy
Price Target: $9 → $5
Current: $0.5897
Upside: +747.89%
May 8, 2026
Reiterated: Buy
Price Target: $24
Current: $12.40
Upside: +93.55%
Apr 15, 2026
Reiterated: Buy
Price Target: $11
Current: $7.41
Upside: +48.45%
Mar 25, 2026
Reiterated: Buy
Price Target: $50
Current: $20.50
Upside: +143.90%
May 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.60
Upside: n/a
Nov 29, 2023
Reiterated: Buy
Price Target: $1.5
Current: $0.0001
Upside: n/a
Apr 12, 2023
Reiterated: Buy
Price Target: $96 → $15
Current: $0.527
Upside: n/a
Sep 16, 2022
Reiterated: Buy
Price Target: $3.5
Current: $0.7858
Upside: n/a
Mar 1, 2022
Reiterated: Buy
Price Target: $60 → $50
Current: $45.23
Upside: n/a